Oncological safety of transanal total mesorectal excision (TaTME) for rectal cancer: mid-term results of a prospective multicentre study
ConclusionsThere is currently a lack of evidence in the literature regarding TaTME and oncological outcomes with no data available from randomized clinical trials. In the meantime, the reported results from different multicentre series are controversial. This study showed positive mid-term outcomes at 2 years of follow-up and supported notable oncological outcomes with TaTME. However, it must be emphasized that previous experience in minimally invasive and transanal surgeries is essential for surgeons before intending to perform TaTME.
Source: Surgical Endoscopy - Category: Surgery Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Endoscopy | Laparoscopy | Minimally Invasive Surgery | Neoadjuvant Therapy | Rectal Cancers | Study | Surgery